nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—Vomiting—Pemetrexed—lung cancer	0.00142	0.00172	CcSEcCtD
Prilocaine—Neuropathy peripheral—Gemcitabine—lung cancer	0.00142	0.00172	CcSEcCtD
Prilocaine—Vomiting—Gefitinib—lung cancer	0.00141	0.00171	CcSEcCtD
Prilocaine—Dysarthria—Methotrexate—lung cancer	0.0014	0.0017	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—CHL1—lung cancer	0.00139	0.0079	CbGpPWpGaD
Prilocaine—Sweating—Gemcitabine—lung cancer	0.00139	0.00168	CcSEcCtD
Prilocaine—Anxiety—Erlotinib—lung cancer	0.00138	0.00167	CcSEcCtD
Prilocaine—Cardiac failure—Docetaxel—lung cancer	0.00136	0.00166	CcSEcCtD
Prilocaine—Bronchospasm—Etoposide—lung cancer	0.00136	0.00165	CcSEcCtD
Prilocaine—Bradycardia—Irinotecan—lung cancer	0.00136	0.00165	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—ROBO1—lung cancer	0.00136	0.00772	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—SLIT2—lung cancer	0.00135	0.00768	CbGpPWpGaD
Prilocaine—Respiratory failure—Methotrexate—lung cancer	0.00135	0.00163	CcSEcCtD
Prilocaine—Anaphylactic shock—Topotecan—lung cancer	0.00134	0.00163	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—CHL1—lung cancer	0.00134	0.00762	CbGpPWpGaD
Prilocaine—Hypersensitivity—Teniposide—lung cancer	0.00133	0.00162	CcSEcCtD
Prilocaine—Oedema—Erlotinib—lung cancer	0.00133	0.00161	CcSEcCtD
Prilocaine—Nausea—Pemetrexed—lung cancer	0.00133	0.00161	CcSEcCtD
Prilocaine—Neuropathy peripheral—Cisplatin—lung cancer	0.00132	0.0016	CcSEcCtD
Prilocaine—Nausea—Gefitinib—lung cancer	0.00132	0.0016	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—CHL1—lung cancer	0.00132	0.00751	CbGpPWpGaD
Prilocaine—Nervous system disorder—Topotecan—lung cancer	0.00132	0.0016	CcSEcCtD
Prilocaine—Extravasation—Doxorubicin—lung cancer	0.00131	0.00159	CcSEcCtD
Prilocaine—Shock—Erlotinib—lung cancer	0.00131	0.00158	CcSEcCtD
Prilocaine—Nervous system disorder—Erlotinib—lung cancer	0.0013	0.00158	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—SLIT2—lung cancer	0.0013	0.0074	CbGpPWpGaD
Prilocaine—Anaemia—Vinorelbine—lung cancer	0.0013	0.00158	CcSEcCtD
Prilocaine—Asthenia—Teniposide—lung cancer	0.0013	0.00158	CcSEcCtD
Prilocaine—Hyperhidrosis—Topotecan—lung cancer	0.0013	0.00157	CcSEcCtD
Prilocaine—Depressed level of consciousness—Methotrexate—lung cancer	0.00128	0.00155	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.00124	0.00708	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—FGFR1—lung cancer	0.00124	0.00706	CbGpPWpGaD
Prilocaine—Paraesthesia—Vinblastine—lung cancer	0.00124	0.0015	CcSEcCtD
Prilocaine—Bradycardia—Cisplatin—lung cancer	0.00123	0.00149	CcSEcCtD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—KDR—lung cancer	0.00122	0.00697	CbGpPWpGaD
Prilocaine—Hypertension—Vinorelbine—lung cancer	0.00121	0.00147	CcSEcCtD
Prilocaine—Dysarthria—Doxorubicin—lung cancer	0.00121	0.00147	CcSEcCtD
Prilocaine—Neuropathy peripheral—Etoposide—lung cancer	0.00121	0.00147	CcSEcCtD
Prilocaine—Paraesthesia—Topotecan—lung cancer	0.0012	0.00146	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—FGFR1—lung cancer	0.00119	0.00679	CbGpPWpGaD
Prilocaine—Arrhythmia—Irinotecan—lung cancer	0.00119	0.00144	CcSEcCtD
Prilocaine—Neuropathy peripheral—Paclitaxel—lung cancer	0.00119	0.00144	CcSEcCtD
Prilocaine—Pain—Vinblastine—lung cancer	0.00118	0.00143	CcSEcCtD
Prilocaine—Arrhythmia—Gemcitabine—lung cancer	0.00116	0.00141	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—SOX2—lung cancer	0.00116	0.00658	CbGpPWpGaD
Prilocaine—Vomiting—Teniposide—lung cancer	0.00115	0.0014	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—FGFR1—lung cancer	0.00115	0.00654	CbGpPWpGaD
Prilocaine—Anaphylactic shock—Vinorelbine—lung cancer	0.00115	0.00139	CcSEcCtD
Prilocaine—Pain—Topotecan—lung cancer	0.00115	0.00139	CcSEcCtD
Prilocaine—Feeling abnormal—Vinblastine—lung cancer	0.00114	0.00138	CcSEcCtD
Prilocaine—Pain—Erlotinib—lung cancer	0.00114	0.00138	CcSEcCtD
Prilocaine—Bronchospasm—Docetaxel—lung cancer	0.00113	0.00137	CcSEcCtD
Prilocaine—Tinnitus—Cisplatin—lung cancer	0.00113	0.00137	CcSEcCtD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—KIT—lung cancer	0.00113	0.00642	CbGpPWpGaD
Prilocaine—Nervous system disorder—Vinorelbine—lung cancer	0.00113	0.00137	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—COL4A2—lung cancer	0.00112	0.0064	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.00112	0.00637	CbGpPWpGaD
Prilocaine—Bradycardia—Paclitaxel—lung cancer	0.00111	0.00134	CcSEcCtD
Prilocaine—Feeling abnormal—Topotecan—lung cancer	0.00111	0.00134	CcSEcCtD
Prilocaine—Hypoaesthesia—Etoposide—lung cancer	0.0011	0.00134	CcSEcCtD
Prilocaine—Hypoaesthesia—Paclitaxel—lung cancer	0.00108	0.00131	CcSEcCtD
Prilocaine—Arrhythmia—Cisplatin—lung cancer	0.00108	0.00131	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—COL4A2—lung cancer	0.00108	0.00615	CbGpPWpGaD
Prilocaine—Nausea—Teniposide—lung cancer	0.00108	0.0013	CcSEcCtD
Prilocaine—Neuropathy—Doxorubicin—lung cancer	0.00107	0.0013	CcSEcCtD
Prilocaine—Hypotension—Vinorelbine—lung cancer	0.00107	0.0013	CcSEcCtD
Prilocaine—Anaemia—Irinotecan—lung cancer	0.00107	0.0013	CcSEcCtD
Prilocaine—Urticaria—Topotecan—lung cancer	0.00107	0.00129	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—ROBO1—lung cancer	0.00104	0.00595	CbGpPWpGaD
Prilocaine—Anaemia—Gemcitabine—lung cancer	0.00104	0.00127	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—COL4A2—lung cancer	0.00104	0.00593	CbGpPWpGaD
Prilocaine—Syncope—Irinotecan—lung cancer	0.00104	0.00126	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—ITGB1—lung cancer	0.00103	0.00588	CbGpPWpGaD
Prilocaine—Paraesthesia—Vinorelbine—lung cancer	0.00103	0.00125	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—COL4A2—lung cancer	0.00103	0.00584	CbGpPWpGaD
Prilocaine—Loss of consciousness—Irinotecan—lung cancer	0.00102	0.00124	CcSEcCtD
Prilocaine—Hypersensitivity—Vinblastine—lung cancer	0.00102	0.00123	CcSEcCtD
Prilocaine—Tinnitus—Paclitaxel—lung cancer	0.00101	0.00123	CcSEcCtD
Prilocaine—Neuropathy peripheral—Docetaxel—lung cancer	0.00101	0.00122	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—ROBO1—lung cancer	0.001	0.00571	CbGpPWpGaD
Prilocaine—Hypertension—Irinotecan—lung cancer	0.001	0.00121	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—SLIT2—lung cancer	0.001	0.0057	CbGpPWpGaD
Prilocaine—Vision blurred—Cisplatin—lung cancer	0.000993	0.0012	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—EPHA7—lung cancer	0.000993	0.00565	CbGpPWpGaD
Prilocaine—Anaphylactoid reaction—Methotrexate—lung cancer	0.000992	0.0012	CcSEcCtD
Prilocaine—Asthenia—Vinblastine—lung cancer	0.000991	0.0012	CcSEcCtD
Prilocaine—Hypersensitivity—Topotecan—lung cancer	0.000989	0.0012	CcSEcCtD
Prilocaine—Tremor—Cisplatin—lung cancer	0.000987	0.0012	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—TF—lung cancer	0.000982	0.00559	CbGpPWpGaD
Prilocaine—Pain—Vinorelbine—lung cancer	0.000982	0.00119	CcSEcCtD
Prilocaine—Hypertension—Gemcitabine—lung cancer	0.000976	0.00118	CcSEcCtD
Prilocaine—Anaemia—Cisplatin—lung cancer	0.000973	0.00118	CcSEcCtD
Prilocaine—Arrhythmia—Paclitaxel—lung cancer	0.000971	0.00118	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—ROBO1—lung cancer	0.000968	0.00551	CbGpPWpGaD
Prilocaine—Asthenia—Topotecan—lung cancer	0.000963	0.00117	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—SLIT2—lung cancer	0.000962	0.00548	CbGpPWpGaD
Prilocaine—Osteoarthritis—Methotrexate—lung cancer	0.00096	0.00116	CcSEcCtD
Prilocaine—Confusional state—Irinotecan—lung cancer	0.000955	0.00116	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—ROBO1—lung cancer	0.000953	0.00543	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—MAP2K1—lung cancer	0.000953	0.00542	CbGpPWpGaD
Prilocaine—Asthenia—Erlotinib—lung cancer	0.000953	0.00116	CcSEcCtD
Prilocaine—Oedema—Irinotecan—lung cancer	0.000947	0.00115	CcSEcCtD
Prilocaine—Anaphylactic shock—Irinotecan—lung cancer	0.000947	0.00115	CcSEcCtD
Prilocaine—Feeling abnormal—Vinorelbine—lung cancer	0.000946	0.00115	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—CHL1—lung cancer	0.000941	0.00536	CbGpPWpGaD
Prilocaine—Shock—Irinotecan—lung cancer	0.000931	0.00113	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NODAL—lung cancer	0.000931	0.0053	CbGpPWpGaD
Prilocaine—Nervous system disorder—Irinotecan—lung cancer	0.000928	0.00113	CcSEcCtD
Prilocaine—Tension—Paclitaxel—lung cancer	0.000928	0.00113	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—SLIT2—lung cancer	0.000928	0.00528	CbGpPWpGaD
Prilocaine—Oedema—Gemcitabine—lung cancer	0.000922	0.00112	CcSEcCtD
Prilocaine—Anaphylactic shock—Gemcitabine—lung cancer	0.000922	0.00112	CcSEcCtD
Prilocaine—Nervousness—Paclitaxel—lung cancer	0.000919	0.00111	CcSEcCtD
Prilocaine—Hypoaesthesia—Docetaxel—lung cancer	0.000917	0.00111	CcSEcCtD
Prilocaine—Hyperhidrosis—Irinotecan—lung cancer	0.000915	0.00111	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—MAP2K1—lung cancer	0.000915	0.00521	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—SLIT2—lung cancer	0.000914	0.0052	CbGpPWpGaD
Prilocaine—Dizziness—Vinblastine—lung cancer	0.000913	0.00111	CcSEcCtD
Prilocaine—Urticaria—Vinorelbine—lung cancer	0.000912	0.00111	CcSEcCtD
Prilocaine—Nervous system disorder—Gemcitabine—lung cancer	0.000904	0.0011	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—NCAM1—lung cancer	0.000904	0.00515	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NODAL—lung cancer	0.000894	0.00509	CbGpPWpGaD
Prilocaine—Anxiety—Cisplatin—lung cancer	0.000894	0.00108	CcSEcCtD
Prilocaine—Anaemia—Etoposide—lung cancer	0.000892	0.00108	CcSEcCtD
Prilocaine—Vision blurred—Paclitaxel—lung cancer	0.000892	0.00108	CcSEcCtD
Prilocaine—Hyperhidrosis—Gemcitabine—lung cancer	0.000891	0.00108	CcSEcCtD
Prilocaine—Dizziness—Topotecan—lung cancer	0.000887	0.00108	CcSEcCtD
Prilocaine—Tremor—Paclitaxel—lung cancer	0.000886	0.00108	CcSEcCtD
Prilocaine—Hypotension—Irinotecan—lung cancer	0.000885	0.00107	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—MAP2K1—lung cancer	0.000882	0.00502	CbGpPWpGaD
Prilocaine—Vomiting—Vinblastine—lung cancer	0.000878	0.00107	CcSEcCtD
Prilocaine—Dizziness—Erlotinib—lung cancer	0.000878	0.00106	CcSEcCtD
Prilocaine—Anaemia—Paclitaxel—lung cancer	0.000874	0.00106	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—NCAM1—lung cancer	0.000869	0.00495	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NODAL—lung cancer	0.000862	0.00491	CbGpPWpGaD
Prilocaine—Hypotension—Gemcitabine—lung cancer	0.000862	0.00105	CcSEcCtD
Prilocaine—Oedema—Cisplatin—lung cancer	0.00086	0.00104	CcSEcCtD
Prilocaine—Anaphylactic shock—Cisplatin—lung cancer	0.00086	0.00104	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000859	0.00104	CcSEcCtD
Prilocaine—Vomiting—Topotecan—lung cancer	0.000853	0.00103	CcSEcCtD
Prilocaine—Cardiac failure—Doxorubicin—lung cancer	0.000851	0.00103	CcSEcCtD
Prilocaine—Paraesthesia—Irinotecan—lung cancer	0.00085	0.00103	CcSEcCtD
Prilocaine—Syncope—Paclitaxel—lung cancer	0.000848	0.00103	CcSEcCtD
Prilocaine—Loss of consciousness—Etoposide—lung cancer	0.000848	0.00103	CcSEcCtD
Prilocaine—Hypersensitivity—Vinorelbine—lung cancer	0.000846	0.00103	CcSEcCtD
Prilocaine—Vomiting—Erlotinib—lung cancer	0.000844	0.00102	CcSEcCtD
Prilocaine—Nervous system disorder—Cisplatin—lung cancer	0.000843	0.00102	CcSEcCtD
Prilocaine—Somnolence—Irinotecan—lung cancer	0.000842	0.00102	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—NCAM1—lung cancer	0.000838	0.00477	CbGpPWpGaD
Prilocaine—Hypertension—Etoposide—lung cancer	0.000833	0.00101	CcSEcCtD
Prilocaine—Loss of consciousness—Paclitaxel—lung cancer	0.000831	0.00101	CcSEcCtD
Prilocaine—Osteoarthritis—Doxorubicin—lung cancer	0.000831	0.00101	CcSEcCtD
Prilocaine—Diplopia—Doxorubicin—lung cancer	0.000831	0.00101	CcSEcCtD
Prilocaine—Hyperhidrosis—Cisplatin—lung cancer	0.000831	0.00101	CcSEcCtD
Prilocaine—Paraesthesia—Gemcitabine—lung cancer	0.000828	0.001	CcSEcCtD
Prilocaine—Asthenia—Vinorelbine—lung cancer	0.000824	0.000999	CcSEcCtD
Prilocaine—Arrhythmia—Docetaxel—lung cancer	0.000823	0.000998	CcSEcCtD
Prilocaine—Nausea—Vinblastine—lung cancer	0.00082	0.000995	CcSEcCtD
Prilocaine—Somnolence—Gemcitabine—lung cancer	0.00082	0.000994	CcSEcCtD
Prilocaine—Hypertension—Paclitaxel—lung cancer	0.000817	0.000991	CcSEcCtD
Prilocaine—Pain—Irinotecan—lung cancer	0.00081	0.000982	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—FGFR1—lung cancer	0.000808	0.0046	CbGpPWpGaD
Prilocaine—Hypotension—Cisplatin—lung cancer	0.000803	0.000974	CcSEcCtD
Prilocaine—Anxiety—Paclitaxel—lung cancer	0.000803	0.000974	CcSEcCtD
Prilocaine—Nausea—Topotecan—lung cancer	0.000797	0.000967	CcSEcCtD
Prilocaine—Confusional state—Etoposide—lung cancer	0.000794	0.000963	CcSEcCtD
Prilocaine—Cardiac arrest—Doxorubicin—lung cancer	0.00079	0.000959	CcSEcCtD
Prilocaine—Pain—Gemcitabine—lung cancer	0.000789	0.000957	CcSEcCtD
Prilocaine—Nausea—Erlotinib—lung cancer	0.000789	0.000957	CcSEcCtD
Prilocaine—Anaphylactic shock—Etoposide—lung cancer	0.000787	0.000955	CcSEcCtD
Prilocaine—Feeling abnormal—Irinotecan—lung cancer	0.00078	0.000946	CcSEcCtD
Prilocaine—Confusional state—Paclitaxel—lung cancer	0.000779	0.000944	CcSEcCtD
Prilocaine—Anaphylactic shock—Paclitaxel—lung cancer	0.000772	0.000937	CcSEcCtD
Prilocaine—Oedema—Paclitaxel—lung cancer	0.000772	0.000937	CcSEcCtD
Prilocaine—Paraesthesia—Cisplatin—lung cancer	0.000772	0.000936	CcSEcCtD
Prilocaine—Hyperhidrosis—Etoposide—lung cancer	0.000761	0.000923	CcSEcCtD
Prilocaine—Feeling abnormal—Gemcitabine—lung cancer	0.00076	0.000922	CcSEcCtD
Prilocaine—Shock—Paclitaxel—lung cancer	0.00076	0.000921	CcSEcCtD
Prilocaine—Dizziness—Vinorelbine—lung cancer	0.000759	0.000921	CcSEcCtD
Prilocaine—Nervous system disorder—Paclitaxel—lung cancer	0.000757	0.000918	CcSEcCtD
Prilocaine—Hyperhidrosis—Paclitaxel—lung cancer	0.000746	0.000905	CcSEcCtD
Prilocaine—Anaemia—Docetaxel—lung cancer	0.000741	0.000899	CcSEcCtD
Prilocaine—Drowsiness—Methotrexate—lung cancer	0.00074	0.000897	CcSEcCtD
Prilocaine—Hypotension—Etoposide—lung cancer	0.000736	0.000893	CcSEcCtD
Prilocaine—Pain—Cisplatin—lung cancer	0.000735	0.000892	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—COL4A2—lung cancer	0.000732	0.00417	CbGpPWpGaD
Prilocaine—Vomiting—Vinorelbine—lung cancer	0.00073	0.000885	CcSEcCtD
Prilocaine—Hypotension—Paclitaxel—lung cancer	0.000721	0.000875	CcSEcCtD
Prilocaine—Syncope—Docetaxel—lung cancer	0.000719	0.000872	CcSEcCtD
Prilocaine—Sweating—Methotrexate—lung cancer	0.000709	0.00086	CcSEcCtD
Prilocaine—Feeling abnormal—Cisplatin—lung cancer	0.000708	0.000859	CcSEcCtD
Prilocaine—Paraesthesia—Etoposide—lung cancer	0.000707	0.000858	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—SOX2—lung cancer	0.000706	0.00402	CbGpPWpGaD
Prilocaine—Loss of consciousness—Docetaxel—lung cancer	0.000705	0.000855	CcSEcCtD
Prilocaine—Somnolence—Etoposide—lung cancer	0.0007	0.000849	CcSEcCtD
Prilocaine—Hypersensitivity—Irinotecan—lung cancer	0.000697	0.000846	CcSEcCtD
Prilocaine—Paraesthesia—Paclitaxel—lung cancer	0.000693	0.000841	CcSEcCtD
Prilocaine—Hypertension—Docetaxel—lung cancer	0.000692	0.00084	CcSEcCtD
Prilocaine—Somnolence—Paclitaxel—lung cancer	0.000686	0.000833	CcSEcCtD
Prilocaine—Nausea—Vinorelbine—lung cancer	0.000682	0.000827	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—AVP—lung cancer	0.000681	0.00388	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ROBO1—lung cancer	0.00068	0.00387	CbGpPWpGaD
Prilocaine—Asthenia—Irinotecan—lung cancer	0.000679	0.000824	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—SOX2—lung cancer	0.000678	0.00386	CbGpPWpGaD
Prilocaine—Pain—Etoposide—lung cancer	0.000673	0.000817	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NCOA3—lung cancer	0.000663	0.00378	CbGpPWpGaD
Prilocaine—Asthenia—Gemcitabine—lung cancer	0.000662	0.000803	CcSEcCtD
Prilocaine—SCN3A—L1CAM interactions—SRC—lung cancer	0.000661	0.00376	CbGpPWpGaD
Prilocaine—Pain—Paclitaxel—lung cancer	0.00066	0.000801	CcSEcCtD
Prilocaine—Confusional state—Docetaxel—lung cancer	0.00066	0.0008	CcSEcCtD
Prilocaine—Anaphylactic shock—Docetaxel—lung cancer	0.000654	0.000794	CcSEcCtD
Prilocaine—Oedema—Docetaxel—lung cancer	0.000654	0.000794	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—SOX2—lung cancer	0.000654	0.00372	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SLIT2—lung cancer	0.000652	0.00371	CbGpPWpGaD
Prilocaine—Feeling abnormal—Etoposide—lung cancer	0.000649	0.000787	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NCAM1—lung cancer	0.000645	0.00367	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—HES1—lung cancer	0.000644	0.00367	CbGpPWpGaD
Prilocaine—Shock—Docetaxel—lung cancer	0.000644	0.000781	CcSEcCtD
Prilocaine—Nervous system disorder—Docetaxel—lung cancer	0.000642	0.000779	CcSEcCtD
Prilocaine—Drowsiness—Doxorubicin—lung cancer	0.00064	0.000777	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL10—lung cancer	0.00064	0.00365	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NCOA3—lung cancer	0.000637	0.00363	CbGpPWpGaD
Prilocaine—Feeling abnormal—Paclitaxel—lung cancer	0.000636	0.000772	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—SRC—lung cancer	0.000635	0.00362	CbGpPWpGaD
Prilocaine—Hypersensitivity—Cisplatin—lung cancer	0.000633	0.000768	CcSEcCtD
Prilocaine—Neuropathy peripheral—Doxorubicin—lung cancer	0.000628	0.000761	CcSEcCtD
Prilocaine—Dizziness—Irinotecan—lung cancer	0.000626	0.000759	CcSEcCtD
Prilocaine—Urticaria—Etoposide—lung cancer	0.000626	0.000759	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—MAP2K1—lung cancer	0.00062	0.00353	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NCAM1—lung cancer	0.00062	0.00353	CbGpPWpGaD
Prilocaine—Tinnitus—Methotrexate—lung cancer	0.000619	0.000751	CcSEcCtD
Prilocaine—Asthenia—Cisplatin—lung cancer	0.000617	0.000748	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NCOA3—lung cancer	0.000615	0.0035	CbGpPWpGaD
Prilocaine—Sweating—Doxorubicin—lung cancer	0.000614	0.000745	CcSEcCtD
Prilocaine—Urticaria—Paclitaxel—lung cancer	0.000613	0.000744	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—SRC—lung cancer	0.000612	0.00349	CbGpPWpGaD
Prilocaine—Hypotension—Docetaxel—lung cancer	0.000612	0.000742	CcSEcCtD
Prilocaine—SCN3A—L1CAM interactions—MAPK3—lung cancer	0.000609	0.00347	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NODAL—lung cancer	0.000606	0.00345	CbGpPWpGaD
Prilocaine—Vomiting—Irinotecan—lung cancer	0.000602	0.00073	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—ITGB1—lung cancer	0.000599	0.00341	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NCAM1—lung cancer	0.000598	0.0034	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—NCAM1—lung cancer	0.000589	0.00335	CbGpPWpGaD
Prilocaine—Paraesthesia—Docetaxel—lung cancer	0.000588	0.000713	CcSEcCtD
Prilocaine—Vomiting—Gemcitabine—lung cancer	0.000586	0.000711	CcSEcCtD
Prilocaine—Bradycardia—Doxorubicin—lung cancer	0.000585	0.00071	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—MAPK3—lung cancer	0.000585	0.00333	CbGpPWpGaD
Prilocaine—Somnolence—Docetaxel—lung cancer	0.000582	0.000706	CcSEcCtD
Prilocaine—Hypersensitivity—Etoposide—lung cancer	0.00058	0.000704	CcSEcCtD
Prilocaine—SCN3A—L1CAM interactions—EGFR—lung cancer	0.000579	0.0033	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—ITGB1—lung cancer	0.000575	0.00328	CbGpPWpGaD
Prilocaine—Hypoaesthesia—Doxorubicin—lung cancer	0.000572	0.000694	CcSEcCtD
Prilocaine—Hypersensitivity—Paclitaxel—lung cancer	0.000569	0.00069	CcSEcCtD
Prilocaine—Asthenia—Etoposide—lung cancer	0.000565	0.000685	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—MAPK3—lung cancer	0.000564	0.00321	CbGpPWpGaD
Prilocaine—Nausea—Irinotecan—lung cancer	0.000562	0.000682	CcSEcCtD
Prilocaine—Pain—Docetaxel—lung cancer	0.00056	0.000679	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—EGFR—lung cancer	0.000557	0.00317	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—ITGB1—lung cancer	0.000555	0.00316	CbGpPWpGaD
Prilocaine—Asthenia—Paclitaxel—lung cancer	0.000554	0.000672	CcSEcCtD
Prilocaine—Nausea—Gemcitabine—lung cancer	0.000548	0.000664	CcSEcCtD
Prilocaine—Vomiting—Cisplatin—lung cancer	0.000547	0.000663	CcSEcCtD
Prilocaine—Vision blurred—Methotrexate—lung cancer	0.000545	0.000661	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.00054	0.00307	CbGpPWpGaD
Prilocaine—Feeling abnormal—Docetaxel—lung cancer	0.000539	0.000654	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—EGFR—lung cancer	0.000537	0.00306	CbGpPWpGaD
Prilocaine—Tinnitus—Doxorubicin—lung cancer	0.000536	0.00065	CcSEcCtD
Prilocaine—Anaemia—Methotrexate—lung cancer	0.000534	0.000648	CcSEcCtD
Prilocaine—Dizziness—Etoposide—lung cancer	0.000521	0.000632	CcSEcCtD
Prilocaine—Arrhythmia—Doxorubicin—lung cancer	0.000514	0.000623	CcSEcCtD
Prilocaine—Dizziness—Paclitaxel—lung cancer	0.000511	0.000619	CcSEcCtD
Prilocaine—Nausea—Cisplatin—lung cancer	0.000511	0.000619	CcSEcCtD
Prilocaine—Vomiting—Etoposide—lung cancer	0.000501	0.000607	CcSEcCtD
Prilocaine—Tension—Doxorubicin—lung cancer	0.000491	0.000596	CcSEcCtD
Prilocaine—Vomiting—Paclitaxel—lung cancer	0.000491	0.000595	CcSEcCtD
Prilocaine—Nervousness—Doxorubicin—lung cancer	0.000486	0.00059	CcSEcCtD
Prilocaine—Hypersensitivity—Docetaxel—lung cancer	0.000482	0.000585	CcSEcCtD
Prilocaine—Confusional state—Methotrexate—lung cancer	0.000476	0.000577	CcSEcCtD
Prilocaine—Anaphylactic shock—Methotrexate—lung cancer	0.000472	0.000572	CcSEcCtD
Prilocaine—Vision blurred—Doxorubicin—lung cancer	0.000472	0.000572	CcSEcCtD
Prilocaine—Asthenia—Docetaxel—lung cancer	0.00047	0.00057	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—FGFR1—lung cancer	0.000469	0.00267	CbGpPWpGaD
Prilocaine—Nausea—Etoposide—lung cancer	0.000468	0.000567	CcSEcCtD
Prilocaine—Nervous system disorder—Methotrexate—lung cancer	0.000463	0.000561	CcSEcCtD
Prilocaine—Anaemia—Doxorubicin—lung cancer	0.000463	0.000561	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—SOX2—lung cancer	0.000459	0.00262	CbGpPWpGaD
Prilocaine—Nausea—Paclitaxel—lung cancer	0.000459	0.000556	CcSEcCtD
Prilocaine—Hyperhidrosis—Methotrexate—lung cancer	0.000456	0.000553	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—FGFR1—lung cancer	0.00045	0.00256	CbGpPWpGaD
Prilocaine—Syncope—Doxorubicin—lung cancer	0.000449	0.000544	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—FOXO3—lung cancer	0.000444	0.00253	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—KDR—lung cancer	0.000442	0.00251	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000441	0.00251	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000441	0.00251	CbGpPWpGaD
Prilocaine—Hypotension—Methotrexate—lung cancer	0.000441	0.000535	CcSEcCtD
Prilocaine—Loss of consciousness—Doxorubicin—lung cancer	0.00044	0.000534	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—FGFR1—lung cancer	0.000434	0.00247	CbGpPWpGaD
Prilocaine—Dizziness—Docetaxel—lung cancer	0.000433	0.000525	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—MET—lung cancer	0.000432	0.00246	CbGpPWpGaD
Prilocaine—Hypertension—Doxorubicin—lung cancer	0.000432	0.000524	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—NCOA3—lung cancer	0.000432	0.00246	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—SRC—lung cancer	0.00043	0.00245	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ITGB1—lung cancer	0.000427	0.00243	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—FOXO3—lung cancer	0.000426	0.00243	CbGpPWpGaD
Prilocaine—Anxiety—Doxorubicin—lung cancer	0.000425	0.000515	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—KDR—lung cancer	0.000424	0.00242	CbGpPWpGaD
Prilocaine—Paraesthesia—Methotrexate—lung cancer	0.000424	0.000514	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—NCAM1—lung cancer	0.00042	0.00239	CbGpPWpGaD
Prilocaine—Somnolence—Methotrexate—lung cancer	0.000419	0.000509	CcSEcCtD
Prilocaine—Vomiting—Docetaxel—lung cancer	0.000416	0.000505	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—MET—lung cancer	0.000415	0.00236	CbGpPWpGaD
Prilocaine—Confusional state—Doxorubicin—lung cancer	0.000412	0.0005	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—FOXO3—lung cancer	0.000411	0.00234	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ITGB1—lung cancer	0.000411	0.00234	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—KDR—lung cancer	0.000409	0.00233	CbGpPWpGaD
Prilocaine—Anaphylactic shock—Doxorubicin—lung cancer	0.000408	0.000495	CcSEcCtD
Prilocaine—Oedema—Doxorubicin—lung cancer	0.000408	0.000495	CcSEcCtD
Prilocaine—Pain—Methotrexate—lung cancer	0.000403	0.000489	CcSEcCtD
Prilocaine—Shock—Doxorubicin—lung cancer	0.000402	0.000487	CcSEcCtD
Prilocaine—Nervous system disorder—Doxorubicin—lung cancer	0.000401	0.000486	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—MET—lung cancer	0.0004	0.00228	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—MAPK3—lung cancer	0.000397	0.00226	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ITGB1—lung cancer	0.000396	0.00225	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Doxorubicin—lung cancer	0.000395	0.000479	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—HES1—lung cancer	0.000393	0.00224	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ITGB1—lung cancer	0.00039	0.00222	CbGpPWpGaD
Prilocaine—Nausea—Docetaxel—lung cancer	0.000389	0.000472	CcSEcCtD
Prilocaine—Feeling abnormal—Methotrexate—lung cancer	0.000389	0.000471	CcSEcCtD
Prilocaine—Hypotension—Doxorubicin—lung cancer	0.000382	0.000463	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—HES1—lung cancer	0.000378	0.00215	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—IL6R—lung cancer	0.000378	0.00215	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—EGFR—lung cancer	0.000377	0.00215	CbGpPWpGaD
Prilocaine—Urticaria—Methotrexate—lung cancer	0.000375	0.000455	CcSEcCtD
Prilocaine—Paraesthesia—Doxorubicin—lung cancer	0.000367	0.000445	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—HES1—lung cancer	0.000364	0.00207	CbGpPWpGaD
Prilocaine—Somnolence—Doxorubicin—lung cancer	0.000363	0.00044	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—IL6R—lung cancer	0.000363	0.00207	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MMP2—lung cancer	0.00036	0.00205	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MAP2K1—lung cancer	0.00036	0.00205	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.00035	0.00199	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—IL6R—lung cancer	0.00035	0.00199	CbGpPWpGaD
Prilocaine—Pain—Doxorubicin—lung cancer	0.000349	0.000424	CcSEcCtD
Prilocaine—Hypersensitivity—Methotrexate—lung cancer	0.000348	0.000422	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—MMP2—lung cancer	0.000346	0.00197	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MAP2K1—lung cancer	0.000346	0.00197	CbGpPWpGaD
Prilocaine—Asthenia—Methotrexate—lung cancer	0.000338	0.000411	CcSEcCtD
Prilocaine—Feeling abnormal—Doxorubicin—lung cancer	0.000337	0.000408	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000335	0.00191	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—FGFR1—lung cancer	0.000335	0.0019	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MMP2—lung cancer	0.000334	0.0019	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MAP2K1—lung cancer	0.000333	0.0019	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—JUN—lung cancer	0.000325	0.00185	CbGpPWpGaD
Prilocaine—Urticaria—Doxorubicin—lung cancer	0.000324	0.000394	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—FGFR1—lung cancer	0.000321	0.00183	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—RAF1—lung cancer	0.000319	0.00182	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—ERBB2—lung cancer	0.000316	0.0018	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KDR—lung cancer	0.000315	0.00179	CbGpPWpGaD
Prilocaine—Dizziness—Methotrexate—lung cancer	0.000312	0.000378	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—FGFR1—lung cancer	0.00031	0.00176	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MET—lung cancer	0.000308	0.00176	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—RAF1—lung cancer	0.000307	0.00175	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—FGFR1—lung cancer	0.000305	0.00174	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—ERBB2—lung cancer	0.000303	0.00173	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KDR—lung cancer	0.000303	0.00172	CbGpPWpGaD
Prilocaine—Hypersensitivity—Doxorubicin—lung cancer	0.000301	0.000365	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—EP300—lung cancer	0.0003	0.00171	CbGpPWpGaD
Prilocaine—Vomiting—Methotrexate—lung cancer	0.0003	0.000364	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—MET—lung cancer	0.000296	0.00169	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—RAF1—lung cancer	0.000296	0.00168	CbGpPWpGaD
Prilocaine—Asthenia—Doxorubicin—lung cancer	0.000293	0.000355	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—ERBB2—lung cancer	0.000293	0.00167	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KDR—lung cancer	0.000292	0.00166	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—FOXO3—lung cancer	0.000289	0.00165	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KDR—lung cancer	0.000288	0.00164	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MET—lung cancer	0.000286	0.00163	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000284	0.00162	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MET—lung cancer	0.000281	0.0016	CbGpPWpGaD
Prilocaine—Nausea—Methotrexate—lung cancer	0.00028	0.00034	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—ITGB1—lung cancer	0.000278	0.00159	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MMP9—lung cancer	0.000271	0.00154	CbGpPWpGaD
Prilocaine—Dizziness—Doxorubicin—lung cancer	0.00027	0.000328	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—IL6R—lung cancer	0.00027	0.00153	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CREBBP—lung cancer	0.000269	0.00153	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MMP9—lung cancer	0.00026	0.00148	CbGpPWpGaD
Prilocaine—Vomiting—Doxorubicin—lung cancer	0.00026	0.000315	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—IL6R—lung cancer	0.000259	0.00147	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CREBBP—lung cancer	0.000259	0.00147	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MMP2—lung cancer	0.000257	0.00146	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MAP2K1—lung cancer	0.000257	0.00146	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HES1—lung cancer	0.000256	0.00146	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MMP9—lung cancer	0.000251	0.00143	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—SRC—lung cancer	0.00025	0.00142	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—IL6R—lung cancer	0.00025	0.00142	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CREBBP—lung cancer	0.000249	0.00142	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MMP2—lung cancer	0.000247	0.00141	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MAP2K1—lung cancer	0.000247	0.00141	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—IL6R—lung cancer	0.000246	0.0014	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—VEGFA—lung cancer	0.000243	0.00139	CbGpPWpGaD
Prilocaine—Nausea—Doxorubicin—lung cancer	0.000243	0.000294	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—NRAS—lung cancer	0.00024	0.00137	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—SRC—lung cancer	0.00024	0.00137	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MMP2—lung cancer	0.000238	0.00136	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAP2K1—lung cancer	0.000238	0.00136	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MMP2—lung cancer	0.000235	0.00134	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MAP2K1—lung cancer	0.000234	0.00133	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—VEGFA—lung cancer	0.000234	0.00133	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—SRC—lung cancer	0.000231	0.00132	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—NRAS—lung cancer	0.000231	0.00131	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MAPK3—lung cancer	0.00023	0.00131	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—RAF1—lung cancer	0.000228	0.0013	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ERBB2—lung cancer	0.000225	0.00128	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—VEGFA—lung cancer	0.000225	0.00128	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—NRAS—lung cancer	0.000223	0.00127	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MAPK3—lung cancer	0.000221	0.00126	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—EGFR—lung cancer	0.000219	0.00125	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—RAF1—lung cancer	0.000219	0.00125	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—FGFR1—lung cancer	0.000218	0.00124	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ERBB2—lung cancer	0.000217	0.00123	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MAPK3—lung cancer	0.000213	0.00121	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—RAF1—lung cancer	0.000211	0.0012	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—EGFR—lung cancer	0.00021	0.0012	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ERBB2—lung cancer	0.000209	0.00119	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—RAF1—lung cancer	0.000208	0.00118	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—KRAS—lung cancer	0.000207	0.00118	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ERBB2—lung cancer	0.000206	0.00117	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KDR—lung cancer	0.000205	0.00117	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—EGFR—lung cancer	0.000203	0.00115	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MET—lung cancer	0.000201	0.00114	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—KRAS—lung cancer	0.000199	0.00113	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL6—lung cancer	0.000197	0.00112	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MMP9—lung cancer	0.000193	0.0011	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—KRAS—lung cancer	0.000192	0.00109	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MMP9—lung cancer	0.000186	0.00106	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—EP300—lung cancer	0.000183	0.00104	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MMP9—lung cancer	0.000179	0.00102	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—SRC—lung cancer	0.000178	0.00101	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MMP9—lung cancer	0.000176	0.001	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—EP300—lung cancer	0.000176	0.001	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—HRAS—lung cancer	0.000176	0.001	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—IL6R—lung cancer	0.000176	0.001	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CREBBP—lung cancer	0.000175	0.000998	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—VEGFA—lung cancer	0.000174	0.000989	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—STAT3—lung cancer	0.000172	0.000979	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NRAS—lung cancer	0.000171	0.000976	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—SRC—lung cancer	0.000171	0.000975	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—EP300—lung cancer	0.00017	0.000967	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—HRAS—lung cancer	0.000169	0.000962	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—IL6—lung cancer	0.000168	0.000958	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MMP2—lung cancer	0.000168	0.000954	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MAP2K1—lung cancer	0.000167	0.000953	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—VEGFA—lung cancer	0.000167	0.00095	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—STAT3—lung cancer	0.000165	0.00094	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—SRC—lung cancer	0.000165	0.00094	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NRAS—lung cancer	0.000165	0.000938	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MAPK3—lung cancer	0.000164	0.000935	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—HRAS—lung cancer	0.000163	0.000927	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—SRC—lung cancer	0.000163	0.000926	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—IL6—lung cancer	0.000162	0.00092	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—VEGFA—lung cancer	0.000161	0.000916	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—STAT3—lung cancer	0.000159	0.000907	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NRAS—lung cancer	0.000159	0.000905	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—VEGFA—lung cancer	0.000158	0.000902	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MAPK3—lung cancer	0.000158	0.000898	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—NRAS—lung cancer	0.000157	0.000891	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—EGFR—lung cancer	0.000156	0.00089	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—IL6—lung cancer	0.000156	0.000888	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAPK3—lung cancer	0.000152	0.000866	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—EGFR—lung cancer	0.00015	0.000855	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MAPK3—lung cancer	0.00015	0.000853	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—RAF1—lung cancer	0.000148	0.000845	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KRAS—lung cancer	0.000148	0.00084	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ERBB2—lung cancer	0.000147	0.000836	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—EGFR—lung cancer	0.000145	0.000824	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—EGFR—lung cancer	0.000143	0.000812	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KRAS—lung cancer	0.000142	0.000807	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KRAS—lung cancer	0.000137	0.000779	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KRAS—lung cancer	0.000135	0.000767	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MMP9—lung cancer	0.000126	0.000717	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—HRAS—lung cancer	0.000125	0.000714	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HRAS—lung cancer	0.000121	0.000686	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—IL6—lung cancer	0.00012	0.000684	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—EP300—lung cancer	0.000119	0.00068	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—HRAS—lung cancer	0.000116	0.000662	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SRC—lung cancer	0.000116	0.000661	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—IL6—lung cancer	0.000115	0.000657	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—HRAS—lung cancer	0.000114	0.000652	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—VEGFA—lung cancer	0.000113	0.000644	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—STAT3—lung cancer	0.000112	0.000637	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NRAS—lung cancer	0.000112	0.000636	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—IL6—lung cancer	0.000111	0.000633	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—AKT1—lung cancer	0.000111	0.000631	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—IL6—lung cancer	0.00011	0.000624	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MAPK3—lung cancer	0.000107	0.000609	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—AKT1—lung cancer	0.000106	0.000606	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—AKT1—lung cancer	0.000103	0.000584	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—EGFR—lung cancer	0.000102	0.000579	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KRAS—lung cancer	9.61e-05	0.000547	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HRAS—lung cancer	8.17e-05	0.000465	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—IL6—lung cancer	7.82e-05	0.000445	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—AKT1—lung cancer	7.21e-05	0.000411	CbGpPWpGaD
